Columbia enacts financial conflicts of interest policy

Share this article:

Columbia University is the latest educational institution to issue guidelines that require faculty members to report any conflicts of interest they might have related to research that they publish. The announcement comes in the wake of increased scrutiny by the federal government in the past several months of researchers' and their financial ties to drug companies and medical device manufacturers.

In October 2008, Senators Charles Grassley (R-IA) and Herb Kohl, (D-WI) looked into the relationship between 22 Columbia professors and device companies.

Columbia sent the guidelines via e-mail to faculty and staff members. The new policy requires individuals to report to the university all financial interests in businesses that fund the individual's research, supply products or technology that are the subject of such research.

The Columbia policy defines financial interest as an interested business or any other financial interest that would reasonably appear to be affected by the outcome of the research at issue, held or received by an individual or his or her family.

The new policy will require that each individual faculty member report to the university all of his/her financial interests at least annually on a form and in a manner approved by the executive vice president for research. Failure to comply with the policy could result in dismissal from the university.

According to the National Science Foundation, Columbia spent about $546 million on research in fiscal year 2007. Recently Johns Hopkins announced a policy that will limit industry interaction with its school of medicine. Industry-funded meals, drug samples and gifts to individuals will be off limits to Johns Hopkins faculty and staff effective July 1, 2009.

Stanford University's School of Medicine adopted a policy that will publicly disclose pharma industry payments to its faculty and staff if these payments exceed $5,000 per year.

Recently, hospitals affiliated with Harvard University's Medical School adopted conflict-of-interest rules designed to eliminate gifts from drug companies.

Share this article:

Email Newsletters

More in News

Five things for pharma marketers to know: Friday, August 22

Five things for pharma marketers to know: Friday, ...

Two new indications give Eliquis more juice, a new rule is making hydrocodone harder to get and the ALS Ice Bucket Challenge highlights a controversial aspects of drug discovery and ...

Lilly takes on Amgen's Enbrel

Lilly takes on Amgen's Enbrel

Phase-III tests indicate Lilly's experimental treatment bests Amgen's for moderate-to-severe plaque psoriasis.

GSK Ellipta franchise expands

GSK Ellipta franchise expands

The FDA has approved Arnuity Ellipta for asthma.